PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18951825-11	2008	RTX is expected to produce important savings (-31%) if used after failure of one or more TNFalpha therapies.	resiniferatoxin	0-3	tumor necrosis factor	Homo sapiens	89-97	
22242698-8	2012	In stark contrast to the untreated fibroblasts, significant calcium signaling in response to capsaicin and resiniferatoxin in HPBFs treated for 24 and 48 hours with TNF-alpha, LPS, or IL-1alpha was also observed.	resiniferatoxin	107-122	tumor necrosis factor	Homo sapiens	165-174	
21925447-14	2011	RESULTS: RTX is an effective drug in three groups of patients with RA: patients who fail to MTX, those who fail anti-TNF and in patients with no prior exposure to MTX.	resiniferatoxin	9-12	tumor necrosis factor	Homo sapiens	117-120	
21925447-18	2011	It was impossible to identify a larger increase in the number of severe infections, probably due to methodological problems, however, the risk of developing infections in patients treated with RTX seems to be comparable to that of other anti-TNF and biologics.	resiniferatoxin	193-196	tumor necrosis factor	Homo sapiens	242-245	
8906816-4	1996	In the present study, we examined the effect of capsaicin and its analogue, resiniferatoxin, on the activation of NF-kappa B induced by different agents including TNF.	resiniferatoxin	76-91	tumor necrosis factor	Homo sapiens	163-166	
35411376-7	2022	Antibody levels were significantly lower in the groups treated with TNF inhibitor (TNFi) with methotrexate (MTX), abatacept, mycophenolate mofetil (MMF), MMF or mizoribine (MMF/MZR) combined with calcineurin inhibitor (CNI), and rituximab or cyclophosphamide (RTX/CPA) compared with those treated with sulfasalazine and/or bucillamine or CNI (p<0.01).	resiniferatoxin	260-263	tumor necrosis factor	Homo sapiens	68-71